articleAnnals of the Rheumatic DiseasesMay 22, 2024Closed access

BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial

WWWeijia WangSHShanzhi HeWZWenli ZhangHZHongyu ZhangVDV. Destéfano

Zhongshan People's Hospital · Peking University Shenzhen Hospital · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

184
total citations
FWCI
74.66
Percentile
100%
References
33
Citations per year

Authors

23

Topics & keywords

Topics
Keywords
  • Medicine
  • Open label
  • CD19
  • Immunology
  • Lupus erythematosus
  • Clinical trial
  • Internal medicine
  • Antibody
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.